Madrid, Spain

Alicia Marcos Liorente

This inventor holds 1 USPTO granted patent. Top assignee: Eli Lilly and Company. Active years: 2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alicia Marcos Liorente. Retrieved from https://idiyas.com/inventor/alicia-marcos-liorente

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Alicia Marcos Liorente: Innovator in Central Nervous System Treatments

Introduction

Alicia Marcos Liorente is a prominent inventor based in Madrid, Spain. She has made significant contributions to the field of pharmacology, particularly in the modulation of excitatory amino acid receptors. Her work is crucial for developing treatments for various disorders affecting the central nervous system.

Latest Patents

Alicia holds a patent for "Excitatory amino acid receptor modulators." This patent describes compounds of the formula (I), where R, R, and X have specific meanings as outlined in the specification. These compounds are designed to modulate metabotropic glutamate receptor function, making them useful in treating central nervous system disorders. She has 1 patent to her name.

Career Highlights

Alicia is currently employed at Eli Lilly and Company, a leading global pharmaceutical company. Her role involves research and development focused on innovative solutions for neurological conditions. Her expertise and dedication have positioned her as a valuable asset in her field.

Collaborations

Alicia has collaborated with notable colleagues, including Ivan Collado Cano and Jesus Ezquerra-Carrera. These partnerships have enhanced her research efforts and contributed to the advancement of her projects.

Conclusion

Alicia Marcos Liorente is a trailblazer in the field of pharmacology, with a focus on central nervous system treatments. Her innovative work and collaborations continue to impact the medical community positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…